Early Detection Research Network

RGS5

Aliases:
This biomarker is also known as:
  • MST092,
  • MSTP106,
  • MST106,
  • regulator of G-protein signaling 5,
  • MST129,
  • regulator of G-protein signalling 5,
  • RGS5,
  • MSTP129,
  • MSTP092,
  • MSTP032,

Description…

RGS5 is a member of the regulators of G protein signaling (RGS) family, which are signal transduction molecules that are involved in the regulation of heterotrimeric G proteins by acting as GTPase activators. RGS5 has been found to be involved in tumor angiogenesis and to antagonize the angiogenic effect of VEGF. Multiple alternatively spliced transcript variants have been found.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Protein
HGNC Name: RGS5

The following organs have data associated with this biomarker…

Attributes

Phase: Two
QA State: Under Review

Overview

RGS5 has been found to be up-regulated in many types of malignant cells, including breast cancer.

Performance Comment

RGS5 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.